AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.6592
-0.0088 (-1.32%)
At close: Jun 22, 2026, 4:00 PM EDT
0.6417
-0.0175 (-2.65%)
Pre-market: Jun 23, 2026, 6:21 AM EDT
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $17.34 million as of June 23, 2026. Its market cap has increased by 110.19% in one year.
Market Cap
17.34M
Enterprise Value
13.72M
1-Year Change
110.19%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $17.34M, a decrease of -72.76%. That is a compound annual growth rate of -22.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 17.34M | 33.17% |
| Dec 31, 2025 | 13.02M | -39.67% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
| Apr 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NewcelX | 18.79M |
| Tempest Therapeutics | 18.51M |
| Passage Bio | 18.35M |
| Pasithea Therapeutics | 18.01M |
| Werewolf Therapeutics | 17.99M |
| GT Biopharma | 17.69M |
| CEL-SCI | 17.65M |
| Exicure | 17.46M |